Disease: triple-negative breast cancer
AssayName: phosphoproteomics
Experiment: In vivo phosphoproteomics
NumberOfSamples: 34 patients
CleavageAgent: trypsin
CleavageAgent: endoproteinase Lys-C
ReductionReagent: TCEP
ReductionReagent: DTT
AlkylationReagent: chloro-acetamide
AlkylationReagent: IAA
Instrument: UltiMate 3000 HPLC system
Instrument: Q Exactive Plus mass spectrometer
Instrument: Proxeon EASY-nLC 1000
Instrument: LTQ-Orbitrap Elite
IonizationType: electrosprayed (1.9 kV)
IonizationType: electrospray voltage was set at 1.7 kV
Temperature: 250 °C
FlowRateChromatogram: 250 nL/min
FlowRateChromatogram: 100 nL/min
GradientTime: 60 min
GradientTime: 90-min
Separation: reverse phase nano-LC-MS/MS
AcquisitionMethod: data-dependent mode
FragmentationMethod: higher-energy collisional dissociation (HCD)
PrecursorMassTolerance: 10 ppm
FragmentMassTolerance: 0.025 Da
MS2MassAnalyzer: Orbitrap
EnrichmentMethod: Ti4+-IMAC